So far, several studies have found that TLR4 polymorphisms influence cancer susceptibility, such as gastric cancer, myeloma and hepatocellular carcinoma (Bagratuni et al., 2016; He et al., 2018; Huang et al., 2017). This evidence concerns the gene TLR4 and cancer.